Shingles is awful, but there may be another reason to get vaccinated. It may fight dementia
A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
Nature2d
New antibiotic for urinary tract infections nabs FDA approval
The FDA has approved GSK’s gepotidacin (Blujepa) for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older. The small-molecule drug is ...
Insider Monkey5d
Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...
Bloomberg L.P.5d
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to accelerate drug development and halt the nation’s slide down global life ...
Insider Monkey6d
Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer discussed. On Tuesday, Jim Cramer, host of Mad Money, defended the growing wave ...
pharmaphorum1d
GSK to accelerate drug discovery with artificial intelligence company
GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...
pharmaphorum2d
GSK says $2.2bn settlement resolves most Zantac litigation
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...